- A geneticist studies a family with an inherited disease and finds that affected individuals have a mutation that changes a GAG codon to a GUG codon. What type of mutation is this, and what is its most likely effect?
Answer: A missense mutation changing glutamic acid to valine, potentially altering protein structure and function depending on the position.
When analyzing genetic mutations, you need to examine how the DNA change affects the resulting protein. This requires understanding the genetic code and different mutation types.
Let's decode what happens with the GAG → GUG change. GAG codes for glutamic acid (a negatively charged, hydrophilic amino acid), while GUG codes for valine (a nonpolar, hydrophobic amino acid). Since only one nucleotide changed (A→U) and it results in a different amino acid, this is a missense mutation.
The correct answer is C because this single nucleotide substitution changes glutamic acid to valine, creating a missense mutation. The functional impact depends on where this change occurs in the protein - if it's in a critical region like an active site or affects protein folding, it could significantly alter function.
Choice A is wrong because this isn't a silent mutation - the amino acid actually changes from glutamic acid to valine. Choice B incorrectly identifies this as a nonsense mutation, but neither GUG nor GAG are stop codons (UAG, UAA, UGA are the stop codons). Choice D describes a frameshift mutation, which requires insertion or deletion of nucleotides that aren't multiples of three - this is a simple substitution that doesn't shift the reading frame.
For mutation questions, always: (1) identify what type of nucleotide change occurred, (2) determine the amino acid change using the genetic code, and (3) classify the mutation type based on its protein-level effect. Remember that missense mutations change one amino acid, nonsense mutations create stop codons, and silent mutations don't change the amino acid sequence.
- A deletion mutation removes three consecutive nucleotides (AAG) from the middle of a protein-coding gene. Compared to the wild-type protein, the mutant protein will most likely:
Answer: Lack one amino acid but maintain the correct reading frame for all remaining downstream amino acids in the protein sequence.
When you encounter deletion mutations in protein-coding genes, the key factor determining the outcome is whether the deletion maintains or disrupts the reading frame. The genetic code is read in triplets (codons), so deletions of multiples of three nucleotides have fundamentally different effects than other deletions.
Since this deletion removes exactly three consecutive nucleotides (AAG), it eliminates one complete codon without shifting the reading frame. The ribosome will simply skip over the missing codon and continue translating the remaining codons normally. This means the mutant protein will be missing exactly one amino acid (the one that AAG coded for), but all downstream amino acids will be identical to the wild-type protein. Answer B correctly describes this outcome.
Answer A is wrong because frameshift effects only occur when the number of deleted nucleotides is not divisible by three. A three-nucleotide deletion maintains the reading frame. Answer C makes the same error, incorrectly assuming a reading frame shift will occur. Answer D is incorrect because simply removing AAG won't create a stop codon - you'd need the deletion to bring together nucleotides that form a stop codon (UAG, UAA, or UGA), which isn't specified in this scenario.
Remember the "rule of three" for mutations: deletions or insertions of nucleotides in multiples of three typically cause in-frame mutations (affecting individual amino acids), while other numbers cause frameshift mutations (affecting everything downstream). This distinction is crucial for predicting the severity of genetic mutations.
- A point mutation changes the sequence from 5'-ATGGCATAA-3' to 5'-ATGGGATAA-3' in a protein-coding gene. Analysis of the resulting protein shows it has normal length but altered function. What can be concluded about this mutation?
Answer: The mutation converted alanine to glycine, replacing a side chain with specific chemical properties with the smallest possible amino acid residue.
When analyzing point mutations in protein-coding genes, you need to translate the DNA sequence to determine how the amino acid sequence changes. This requires understanding the genetic code and how single nucleotide changes affect protein structure and function.
Let's examine the mutation: 5'-ATGGCATAA-3' becomes 5'-ATGGGATAA-3'. The change is C→G in the fourth position. Reading in triplets from the start codon ATG, the original sequence codes for Met-Ala-Stop, while the mutated sequence codes for Met-Gly-Stop. This changes the second amino acid from alanine (GCA codon) to glycine (GGA codon).
Answer C correctly identifies this as an alanine-to-glycine substitution. Alanine has a methyl group side chain that provides some steric bulk and hydrophobic character, while glycine has only a hydrogen atom as its side chain, making it the smallest amino acid with maximum flexibility. This substitution could significantly alter protein folding or active site geometry while maintaining normal protein length.
Answer A is wrong because this isn't synonymous—the amino acid sequence does change. Answer B incorrectly calls this "conservative"—alanine to glycine is actually a significant change since you're replacing a side chain with chemical properties with essentially no side chain at all. Answer D is wrong because the mutation directly changes an amino acid in the primary sequence rather than affecting a post-translational modification site.
Remember: Always translate both sequences when analyzing mutations. The genetic code determines whether changes are synonymous, conservative, or dramatic like this alanine-to-glycine switch.
- A researcher identifies a point mutation in the third position of a codon that changes UUC to UUU. Analysis reveals that both the wild-type and mutant proteins have identical amino acid sequences and functions. This observation can best be explained by:
Answer: The mutation created a synonymous codon change due to degeneracy of the genetic code, with both codons specifying the same amino acid.
When you encounter questions about point mutations and their effects on proteins, focus on how the genetic code's structure determines whether a DNA change will impact the final protein product.
The genetic code is degenerate, meaning multiple codons can specify the same amino acid. This degeneracy is most pronounced in the third position of codons, where changes often don't alter the amino acid sequence. In this case, both UUC and UUU code for phenylalanine, so the mutation creates a synonymous substitution - the DNA changed, but the protein remains identical. This explains why both the amino acid sequence and protein function are unchanged.
Let's examine why the other options are incorrect:
A is wrong because the mutation clearly occurred in a coding region - we're told it's in the third position of a codon, which by definition is part of the protein-coding sequence.
C misrepresents the scenario. DNA repair mechanisms don't "correct" the mutation during protein synthesis. The mutation exists in the DNA, but it simply doesn't change the amino acid due to genetic code degeneracy.
D incorrectly suggests the mutation only affects mRNA secondary structure. While mRNA folding could theoretically be altered, the question states that both proteins have identical sequences and functions, indicating the synonymous nature of the codon change is the primary explanation.
Study tip: Remember that third-position codon changes are often "silent" due to genetic code degeneracy. When analyzing point mutations, always check if the new codon codes for the same amino acid before considering more complex explanations.
- In a bacterial culture, researchers observe that a specific gene appears to have a much higher mutation rate than other genes in the same cells. What characteristic of this gene most likely explains this observation?
Answer: The gene contains repetitive sequences or palindromic regions that can form secondary structures prone to replication errors.
When you encounter questions about elevated mutation rates in specific genes, think about the structural features that make DNA sequences particularly vulnerable to replication errors or damage.
The correct answer is C because repetitive sequences and palindromic regions create significant challenges during DNA replication. These sequences can form secondary structures like hairpins, loops, or slipped-strand structures that cause DNA polymerase to pause, backtrack, or skip sections. This leads to insertion/deletion mutations, strand slippage events, and increased error rates. Palindromic sequences are especially problematic because complementary regions can base-pair with themselves, creating complex secondary structures that interfere with normal replication machinery.
Let's examine why the other options don't explain elevated mutation rates. Option A incorrectly suggests GC-rich regions are more mutation-prone due to deamination, but spontaneous deamination actually affects cytosine bases regardless of overall GC content, and GC-rich regions aren't inherently more susceptible. Option B misunderstands replication mechanics—genes near replication origins aren't replicated multiple times per cycle; they're simply replicated earlier, which doesn't increase mutation rates. Option D presents an illogical scenario where DNA repair proteins would somehow increase their own gene's mutation rate through positive feedback, but repair proteins actually work to maintain genomic stability.
For college biology exams, remember that structural complexity in DNA sequences—particularly repetitive elements, palindromes, and regions that can form secondary structures—creates replication challenges that manifest as elevated mutation rates. Look for these sequence characteristics when analyzing genes with unusual mutational behavior.
- A clinical geneticist analyzes a patient with a genetic disorder and finds that the causative mutation affects mRNA splicing, resulting in retention of an intron that contains a stop codon. What is the most likely consequence for the resulting protein?
Answer: The protein will be truncated when translation terminates at the retained intron's stop codon, producing a shorter, likely nonfunctional product.
When you encounter questions about splicing defects in genetics, focus on what happens to the mRNA and how that affects protein translation. Normal splicing removes introns from pre-mRNA, leaving only exons in the mature mRNA that gets translated.
In this case, a splicing mutation causes intron retention, meaning an intron stays in the mature mRNA. Since this retained intron contains a stop codon, translation will terminate prematurely when the ribosome encounters it. The result is a truncated (shortened) protein that ends abruptly in the middle of what should be the normal sequence. This premature termination typically renders the protein nonfunctional because it lacks essential domains needed for proper structure and activity, making B correct.
Let's examine why the other options miss the mark. Option A incorrectly assumes translation continues past the stop codon - but stop codons always terminate translation, so no additional amino acids would be added beyond that point. Option C makes the same error, suggesting the protein maintains normal length despite the stop codon, which is impossible since translation must halt. Option D overestimates cellular quality control - while nonsense-mediated decay can degrade some aberrant mRNAs, it doesn't catch all splicing errors, and many defective mRNAs do get translated into truncated proteins.
Remember this key principle: when analyzing splicing defects, always trace through what happens during translation. If the retained sequence contains a stop codon, translation stops there - no exceptions. This creates truncated proteins that are typically nonfunctional.
- Refer to the figure. A chemist treats cells with a mutagen that specifically causes A-T to G-C transitions. Based on the original DNA sequence shown, what would be the amino acid sequence of the protein produced from the mutated gene if the first adenine is changed to guanine?
Answer: Met-Ala-Ser-Leu-Trp, because the A to G change alters the second codon from GAC to GGC, changing aspartic acid to alanine.
The original sequence shows ATG GAC TCC CTG TGG (Met-Asp-Ser-Leu-Trp). Changing the first A to G after the start codon changes GAC to GGC. GAC codes for aspartic acid and GGC codes for alanine, so the new sequence becomes Met-Ala-Ser-Leu-Trp. Choice A is wrong because GGC isn't a stop codon. Choice B is wrong because GGC codes for alanine, not glycine (glycine codons are GGA, GGG, GGU, GGC). Choice D identifies the wrong codon position - the change affects the second codon (GAC→GGC), not the third. Choice E is wrong because the start codon (ATG) remains unchanged.
- A missense mutation in a gene encoding a metabolic enzyme results in the substitution of a charged amino acid with a nonpolar amino acid at position 45. The mutant protein is produced at normal levels but shows 15% of normal enzymatic activity. What is the most likely explanation for this observation?
Answer: The mutation altered the enzyme's active site structure, reducing substrate binding affinity or catalytic efficiency while maintaining overall protein stability and expression.
When analyzing mutations and their effects on protein function, you need to connect the type of mutation to the observed phenotype. This question tests your understanding of how amino acid substitutions can affect enzyme function while leaving protein stability intact.
The key clues here are that protein production is normal but enzymatic activity is severely reduced (15% of normal). This pattern suggests the protein folds properly and is stable enough to avoid degradation, but has compromised catalytic function. A missense mutation changing a charged amino acid to a nonpolar one at position 45 likely altered the enzyme's three-dimensional structure around the active site. This structural change could reduce substrate binding affinity or disrupt the precise geometry needed for efficient catalysis, explaining why some activity remains but is significantly impaired.
Option B is incorrect because missense mutations produce full-length proteins with single amino acid changes, not premature stop codons that create truncated proteins. Option C is wrong because the mutation affects the coding sequence, not the promoter region—and normal protein levels were observed, ruling out transcriptional problems. Option D is incorrect because missense mutations involve single nucleotide changes that don't shift the reading frame; frameshift mutations would likely cause complete loss of function and protein instability.
The correct answer is A, which accurately describes how active site disruption can reduce enzymatic efficiency while maintaining protein stability.
Study tip: When you see normal protein expression but reduced function, think active site disruption rather than protein stability issues. Connect the mutation type directly to the phenotype described.
- A loss-of-function mutation in a gene causes a recessive genetic disorder. However, individuals who are heterozygous for this mutation show no symptoms. At the molecular level, this pattern most likely occurs because:
Answer: One functional copy of the gene produces enough protein to exceed the minimum threshold required for normal cellular processes and phenotype.
When you encounter questions about recessive genetic disorders and heterozygote phenotypes, you're dealing with gene dosage effects and the concept of haploinsufficiency. The key insight is understanding how much functional protein is actually needed for normal cellular function.
In most cases, cells don't require 100% of their maximum protein production capacity to function normally. Instead, there's typically a threshold level of protein activity below which problems occur, but above which everything works fine. This explains why heterozygotes for recessive loss-of-function mutations are usually phenotypically normal.
Option C is correct because one functional gene copy typically produces sufficient protein to exceed the minimum threshold needed for normal cellular processes. Even though protein levels might be reduced compared to homozygous normal individuals, they remain above the critical functional threshold.
Option A is incorrect because compensatory upregulation doesn't typically double expression to fully compensate for the lost allele. Option B mischaracterizes the scenario—we're told this is a loss-of-function mutation, meaning the mutant allele produces non-functional protein, not partially functional protein. Option D incorrectly suggests epigenetic silencing of the mutant allele, but heterozygotes typically express both alleles; the key is that one functional copy is simply sufficient.
Remember this principle: for most genes, having 50% normal protein levels (from one functional allele) is enough to maintain normal function. Only when protein requirements are very high do you see haploinsufficiency, where heterozygotes show symptoms.
- An investigator studies two different mutations in the same gene: Mutation 1 is a single nucleotide deletion, and Mutation 2 is a three-nucleotide deletion. Which prediction about their relative effects is most accurate?
Answer: Mutation 1 will likely have more severe effects because it causes a frameshift that alters the entire downstream protein sequence.
When analyzing genetic mutations, you need to understand how deletions affect the reading frame - the way DNA is read in groups of three nucleotides (codons) during protein synthesis.
A single nucleotide deletion shifts the entire reading frame downstream from the mutation site. This frameshift means every codon after the deletion will be read incorrectly, typically producing a completely different amino acid sequence and often creating a premature stop codon. The result is usually a nonfunctional protein that's either truncated or has a dramatically altered structure.
In contrast, a three-nucleotide deletion removes exactly one codon without shifting the reading frame. While this eliminates one amino acid from the protein, the rest of the sequence remains correct. The protein may still function, albeit potentially with reduced efficiency.
Choice A correctly identifies that Mutation 1 (single nucleotide deletion) will likely be more severe due to its frameshift effect. Choice B incorrectly assumes deletion size correlates with severity - the three-nucleotide deletion is actually larger but less disruptive. Choice C wrongly suggests equivalent effects, ignoring the fundamental difference between frameshift and in-frame deletions. Choice D makes the opposite error, claiming single nucleotide changes are milder, but this ignores that deletions behave differently than substitutions.
Remember this key principle: frameshift mutations (insertions or deletions not divisible by three) typically cause more severe effects than in-frame mutations, regardless of size. The reading frame is crucial for proper protein synthesis.
- A single nucleotide insertion near the beginning of a gene's coding sequence results in a protein that is completely different from the wild-type version and shows no functional activity. What molecular mechanism best explains this outcome?
Answer: The insertion caused a frameshift mutation, altering the reading frame and changing every amino acid downstream from the insertion point.
When analyzing mutations that completely eliminate protein function, you need to consider how different types of genetic changes affect the translation process and final protein product.
A frameshift mutation occurs when nucleotides are inserted or deleted in numbers that aren't multiples of three. Since the genetic code is read in triplets (codons), a single nucleotide insertion shifts the entire reading frame downstream from the mutation site. This means every codon after the insertion point codes for different amino acids than in the wild-type sequence, producing a completely altered protein with no functional similarity to the original. This explains why the mutant protein shows no activity—it's essentially an entirely different protein.
Option A is incorrect because the insertion is specifically described as being in the coding sequence, not the promoter region. A promoter disruption would prevent transcription entirely, not produce a dysfunctional protein. Option B misidentifies the mechanism—while mRNA secondary structure can affect translation, a single nucleotide insertion in the coding sequence wouldn't typically prevent ribosome binding to the start codon located upstream. Option D describes a possible outcome but not the primary mechanism. While frameshift mutations can eventually encounter stop codons, the question emphasizes that a completely different protein is produced, which is the direct result of the altered reading frame.
Remember that frameshift mutations are among the most severe types of point mutations because they affect every amino acid downstream from the insertion or deletion point, making functional protein recovery extremely unlikely.
- An investigator discovers that a particular mutation increases the rate of spontaneous mutations in other genes throughout the genome. This mutation most likely affects a gene encoding:
Answer: A DNA repair enzyme responsible for correcting replication errors, allowing more mutations to accumulate and persist in the genome.
When you encounter questions about mutations that increase genome-wide mutation rates, think about the cellular mechanisms that normally prevent mutations from occurring or persisting. This points directly to DNA repair systems.
DNA repair enzymes are your genome's quality control system. They constantly scan DNA for errors introduced during replication, damage from environmental factors, or spontaneous chemical changes. When these repair mechanisms fail, mutations accumulate throughout the genome because errors that would normally be corrected are left unchecked. This creates the exact scenario described—a single mutation (in a repair gene) leading to increased mutations everywhere else.
Option B correctly identifies this mechanism. A defective DNA repair enzyme would allow replication errors and spontaneous DNA damage to persist rather than being corrected, directly causing the genome-wide increase in mutation rate.
Option A involves translation errors that would affect protein function but wouldn't directly increase DNA mutations. While misfolded proteins might have secondary effects, this doesn't explain the primary mechanism of increased genomic mutations.
Option C focuses on cell cycle regulation. While faster division might increase total replication events, normal DNA repair systems would still correct errors at their usual rate, so this wouldn't dramatically increase the per-cell mutation rate.
Option D suggests altered nucleotide availability could affect mutation rates, but cells tightly regulate nucleotide pools, and this mechanism is less direct than defective repair systems.
Remember: when you see "increased mutations throughout the genome," immediately consider DNA repair defects as the most likely cause—it's the most direct pathway from one genetic defect to widespread genomic instability.
- Analysis of a mutant cell line reveals that a specific protein is completely absent, despite normal mRNA levels for the corresponding gene. Sequencing shows a C to T transition mutation within the coding region. What type of mutation most likely occurred?
Answer: A nonsense mutation that converted an amino acid codon to a premature stop codon, terminating translation early.
When analyzing mutations and their effects on protein production, you need to consider the relationship between DNA sequence changes, mRNA levels, and final protein output. The key clue here is that mRNA levels are normal but the protein is completely absent—this tells you the problem occurs during translation, not transcription.
A C to T transition that eliminates protein production despite normal mRNA strongly suggests a nonsense mutation. This type of mutation converts a codon that normally codes for an amino acid (like CAG for glutamine) into a stop codon (like TAG). When the ribosome encounters this premature stop codon during translation, it terminates protein synthesis early, producing a truncated, non-functional protein that's typically degraded quickly. This explains why you see no detectable protein despite normal mRNA levels.
Let's examine why the other options don't fit: Option A describes a silent mutation, but these don't change amino acids and rarely eliminate protein production entirely. Option B suggests a missense mutation creating an unstable protein, but complete absence is more characteristic of nonsense mutations than missense mutations, which usually produce some detectable altered protein. Option D proposes a regulatory mutation affecting transcription, but this contradicts the given information that mRNA levels are normal.
Study tip: Remember the hierarchy: DNA → mRNA → protein. When mRNA is normal but protein is absent, focus on translation problems. Nonsense mutations are classic culprits for complete protein loss with normal transcript levels.
- A mutation in the gene encoding ribosomal protein S12 confers resistance to streptomycin, an antibiotic that normally binds to the 30S ribosomal subunit and causes misreading of mRNA. What is the most likely effect of this mutation on the cell?
Answer: Reduced translation accuracy or efficiency as a trade-off for antibiotic resistance, potentially affecting overall cellular fitness under normal conditions.
When you encounter questions about antibiotic resistance mutations, remember that evolution rarely provides "free lunches" – gaining resistance typically comes with trade-offs that affect cellular fitness.
Streptomycin works by binding to ribosomal protein S12 in the 30S subunit, causing the ribosome to misread mRNA and produce faulty proteins. A mutation in S12 that confers resistance must alter the protein's structure enough to prevent streptomycin binding. However, since S12 plays a crucial role in translation accuracy, changing its structure will likely impact normal ribosomal function.
The correct answer is C because mutations that block antibiotic binding sites often compromise the protein's normal function. The cell gains resistance but at the cost of reduced translation accuracy or efficiency. This represents a classic evolutionary trade-off – the mutation is beneficial when streptomycin is present but may reduce fitness under normal conditions.
Option A is incorrect because resistance mutations typically don't improve normal cellular functions – they're defensive adaptations that usually carry costs. Option B overstates the impact; while the mutation affects ribosomal function, it doesn't completely eliminate protein synthesis – the cell remains viable. Option D incorrectly suggests that a single ribosomal protein mutation would provide broad antibiotic resistance and improve efflux mechanisms, which are unrelated functions.
Remember this principle: antibiotic resistance mutations are evolutionary compromises. The cell sacrifices some normal function to survive antibiotic exposure, which explains why resistant bacteria often grow more slowly than their sensitive counterparts in antibiotic-free environments.
- A researcher identifies a mutation that occurs specifically during DNA replication in rapidly dividing cells but not in non-dividing cells. This mutation pattern most likely results from:
Answer: Replication fork stalling at difficult-to-replicate sequences, causing DNA polymerase slippage and subsequent insertion or deletion mutations during synthesis.
When analyzing mutations that occur specifically during DNA replication in dividing cells, focus on processes that are unique to or intensified during active DNA synthesis, rather than general cellular damage mechanisms.
The correct answer is C because replication fork stalling represents a replication-specific problem. During DNA synthesis, polymerases can encounter difficult sequences like repetitive DNA, secondary structures, or damaged templates that cause the replication machinery to pause or stall. When this happens, DNA polymerase can slip along the template strand, leading to characteristic insertion or deletion mutations (indels). This mechanism is directly tied to the replication process itself and wouldn't occur in non-dividing cells where DNA isn't being actively synthesized.
Option A is incorrect because mismatch repair defects would cause mutations in both dividing and non-dividing cells whenever DNA damage occurs, not specifically during replication. Option B describes oxidative damage, which affects all metabolically active cells regardless of their division status - you'd see mutations in both dividing and non-dividing cells. Option D misrepresents how DNA repair works; repair systems don't become "enhanced" during division and don't paradoxically introduce errors while fixing damage.
For college biology exams, remember that replication-specific mutations typically involve mechanical problems during DNA synthesis - polymerase errors, fork stalling, or replication stress. These contrast with general mutagenic factors like chemicals or radiation that affect all cells equally regardless of division status.
- Based on the diagram shown, what would be the most likely consequence if a mutation eliminated the normal stop codon and the next downstream stop codon was located 150 nucleotides further along the mRNA?
Answer: Translation would continue past the normal termination site, adding 50 extra amino acids to the C-terminus of the protein.
If the normal stop codon is eliminated (likely changed to a sense codon), the ribosome will continue translating until it encounters the next stop codon. Since this is 150 nucleotides downstream, and each amino acid is encoded by 3 nucleotides, the protein will have 150 ÷ 3 = 50 additional amino acids added to its C-terminus. Choice A is wrong because ribosomes don't proofread for 'correct' stop positions - they translate until they encounter a stop codon. Choice C is wrong because the mRNA remains functional for translation. Choice D is wrong because eliminating a stop codon doesn't cause a frameshift. Choice E is wrong because nonsense-mediated decay is triggered by premature stop codons, not read-through mutations.
- A researcher comparing normal and mutant cell lines finds that both produce equal amounts of a specific mRNA, but the mutant cells produce a protein that is 25 amino acids shorter than normal. What type of mutation most likely occurred?
Answer: A nonsense mutation created a premature stop codon, causing early termination of translation before reaching the normal stop site.
When you encounter questions about mutations affecting protein length but not mRNA levels, focus on distinguishing between transcriptional and post-transcriptional effects. Since both cell lines produce equal mRNA amounts, the mutation doesn't affect gene expression or mRNA stability—it affects translation.
A protein that's exactly 25 amino acids shorter suggests premature translation termination. This occurs when a nonsense mutation creates a stop codon (UAG, UAA, or UGA) earlier in the sequence than normal. The ribosome encounters this premature stop signal and releases the shortened protein. Answer B correctly identifies this scenario.
Let's examine why the other options don't fit. Answer A describes a 75-nucleotide deletion maintaining the reading frame. While this would shorten the protein, it would remove 25 amino acids from the middle, not create a truncated protein ending early. Answer C suggests a frameshift mutation, but frameshifts typically produce proteins with altered amino acid sequences after the mutation site, often resulting in longer proteins due to read-through into new stop codons, not consistently shorter ones. Answer D proposes a splice site mutation removing 75 nucleotides during mRNA processing. However, this would affect the mRNA itself, likely making it detectable as a size difference between normal and mutant mRNA molecules.
Remember this pattern: when mRNA levels are normal but protein length is reduced uniformly, think nonsense mutations creating premature stop codons. This is a common molecular biology exam scenario that tests your understanding of the translation process versus transcription and RNA processing.
- A temperature-sensitive mutation in a gene produces a protein that functions normally at 25°C but loses activity at 37°C. At the molecular level, this mutation most likely:
Answer: Introduced amino acid changes that destabilize the protein's three-dimensional structure, causing unfolding or misfolding at physiological temperatures.
Temperature-sensitive mutations reveal how protein structure relates to function. When you encounter these questions, think about what molecular change could cause normal function at one temperature but dysfunction at another.
The key insight is that this mutation produces a protein that works at 25°C but fails at 37°C. This temperature dependence strongly suggests the protein itself is unstable at higher temperatures. Answer C correctly identifies that amino acid changes destabilized the protein's three-dimensional structure, causing it to unfold or misfold at physiological temperatures. Proteins are held together by weak interactions (hydrogen bonds, van der Waals forces) that become disrupted at higher temperatures when the structure is already compromised by mutation.
Answer A is incorrect because if transcription were temperature-dependent, you'd expect reduced mRNA production at 37°C, but the question states the protein functions normally at 25°C, suggesting adequate mRNA is produced at both temperatures. Answer B fails because unstable mRNA would affect protein production at both temperatures, not create temperature-specific protein dysfunction. Answer D is wrong because ribosome binding site problems would impact translation efficiency at both temperatures, not cause a functional protein to lose activity after it's made.
Remember that temperature-sensitive mutations typically affect protein stability rather than gene expression or translation machinery. When you see normal function at low temperatures but loss of function at higher temperatures, think protein folding and structural stability first.
